- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT04543435
Investigation of Pain Coping Methods and Related Factors in Postmenopausal Women
Aperçu de l'étude
Statut
Les conditions
Description détaillée
Musculoskeletal pain (MSP) reflects of musculoskeletal conditions related to tissues such as tendons, muscles, ligaments, nerves, and other joint structures. If MSP lasts for longer than three months, it becomes chronic. The prevalence of chronic MSP (cMSP) increases with aging and its ratio changes between 35,7% and 49,8%. The previous studies demonstrated the differences in the prevalence of cMSP between men and women. According to most of the studies, older women adults are more vulnerable to experience than men due to some differences in perception of pain such as biological characteristics, their roles in daily life, beliefs or coping strategies with pain.
Oestrogen has a prominent role in the physiology of muscles, tendons, ligaments, and bones. The decline of this sex hormone during menopause transition could lead to MSP, particularly in the postmenopausal period. Indeed, an increasing rate of cMSP in postmenopausal women has been reported.
Coping strategies with pain are used to manage the pain and its impacts. Coping with pain requires the self-regulation of individuals using cognitive and behavioral reactions. Dealing with cMSP is a process that can need the making of changes in daily life and activities This study aimed to compare active and passive coping strategies being used and pain severity in postmenopausal women according to their age, marital status, educational status, and exercise habits. Also, subdomains of strategies and subdomains of pain and the relationship between pain and coping strategies in postmenopausal women with cMSP will be examined.
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
-
Mersin, Turquie
- European University of Lefke
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- complaints of pain in anywhere of their body.
- presenting at least 1 year of amenorrhea
- being between the ages of 50-69 years.
Exclusion Criteria:
- have rheumatological, orthopedic and neurological diseases,
- have compression fractures, malignancies,
- have a chronic disease that will lead to secondary osteoporosis,
- have a drug use that will lead to secondary osteoporosis
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
McGill Pain Questionnaire
Délai: 15 minutes
|
This tool is used for assesment of pain, namely; body part of pain, timeframe, characteristic and severity of pain.
As score increases, pain condition worsens.
|
15 minutes
|
|
Pain Coping Inventory (PCI)
Délai: 10 minutes
|
This tool is used for assessment of pain coping strategies.
The higher score received means that coping strategy is used more.
|
10 minutes
|
|
Timed up and go test
Délai: 5 minutes
|
This tool is used for assessment of functional mobility.
The duration to complete the task (in seconds) is used as a score.
As the score increase, the functional mobility decrease.
|
5 minutes
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Beliz B Kaygısız, PT, PhD, European University of Lefke
- Directeur d'études: Nuray ELİBOL, Ege university
- Chaise d'étude: Sevim Acaröz Candan, T.C. ORDU ÜNİVERSİTESİ
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- ÜEK/47/01/12/1920/05
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .